Showing results (91-100 of 113) with videos related to
Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Phase I and pharmacokinetic study of AI-850, a novel microparticle hydrophobic drug delivery system for paclitaxelAlain C Mita, Anthony J Olszanski, Richard C Walovitch, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2004
Safety, pharmacokinetics, and activity of ABX-EGF, a fully human anti-epidermal growth factor receptor monoclonal antibody in patients with metastatic renal cell cancerEric K Rowinsky, Garry H Schwartz, Jared A Gollob, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
A Phase I and pharmacokinetic study of squalamine, an aminosterol angiogenesis inhibitorDesirée Hao, Lisa A Hammond, S Gail Eckhardt, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Phase I and pharmacokinetic study of pemetrexed with high-dose folic acid supplementation or multivitamin supplementation in patients with locally advanced or metastatic cancerChris H Takimoto, Lisa A Hammond-Thelin, Jane E Latz, et al.Cancer Chemotherapy and Pharmacology|May 19, 2009
Phase I and pharmacokinetic study of cisplatin and troxacitabine administered intravenously every 28 days in patients with advanced solid malignanciesChia-Chi Lin, Muralidhar Beeram, Eric K Rowinsky, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Polymorphisms in cyclooxygenase-2 and epidermal growth factor receptor are associated with progression-free survival independent of K-ras in metastatic colorectal cancer patients treated with single-agent cetuximabGeorg Lurje, Fumio Nagashima, Wu Zhang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Two drug interaction studies evaluating the pharmacokinetics and toxicity of pemetrexed when coadministered with aspirin or Ibuprofen in patients with advanced cancerChristopher J Sweeney, Chris H Takimoto, Jane E Latz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
A phase I and pharmacokinetic study of ecteinascidin-743 on a daily x 5 schedule in patients with solid malignanciesMiguel A Villalona-Calero, S Gail Eckhardt, Geoffrey Weiss, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2004
ING-1, a monoclonal antibody targeting Ep-CAM in patients with advanced adenocarcinomasJohann S de Bono, Anthony W Tolcher, Andre Forero, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
A phase I, pharmacokinetic, and biological study of the farnesyltransferase inhibitor tipifarnib in combination with gemcitabine in patients with advanced malignanciesAmita Patnaik, S Gail Eckhardt, Elzbieta Izbicka, et al.Pageof 12